New pharma Azadyne raises £1.5m for autoimmune disease treatment
The Trinity College spin-off has completed a £1.5-million funding round for its autoimmune treatments.
Read More
Tag: guanine transglycosylase
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
